Navigation Links
CVS Caremark Industry-Leading Generic Dispensing Rate Reduces Client Traditional Drug Spend by 3.6 Percent for 2012
Date:4/11/2013

WOONSOCKET, R.I., April 11, 2013 /PRNewswire/ -- CVS Caremark (NYSE: CVS) today released its annual Insights report, which reviews drug trend and highlights key issues in pharmacy care.  In a pivotal finding, the 2012 analysis revealed that the increased availability of generics combined with CVS Caremark's industry-leading generic dispensing rate (GDR) of 77.4 percent helped reduce spending on traditional medications by 3.6 percent for the company's commercial clients (i.e., health plans and employers).

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO)

CVS Caremark's industry-leading GDR is the result of two key elements.  First, 2012 marked a high point in the flood of generic launches, with the estimated market value of brands that lost their patents in 2012 exceeding $35 billion.  Second, CVS Caremark worked closely with PBM clients to maximize the cost-saving opportunities posed by generics as broadly as possible, using strategies such as formulary management and step therapy plan designs to encourage the use of cost-effective generic drugs. In fact, 70 percent of CVS Caremark plan sponsors use generic step therapy or are considering implementing it in the near future.

While spending for traditional medications decreased, spending on specialty medications grew by 18.1 percent for commercial clients, becoming the main driver of overall drug trend of 0.3 percent. Specialty drugs treat more complex diseases such as multiple sclerosis, rheumatoid arthritis, hepatitis C and cancer.  Overall, specialty drugs now represent nearly 20 percent of total drug spend among CVS Caremark clients, growing by three percentage points and representing the largest increase in the past six years.

"As the generic wave begins to subside in the
'/>"/>

SOURCE CVS Caremark
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CVS Caremark Charitable Trust Supports Non-profits Nationwide with $2.6 Million in Funding
2. CVS Caremark Research Finds Medication Adherence Can Improve Outcomes and Reduce Costs for Patients with Coronary Artery Disease
3. CVS Caremark MinuteClinic President Discusses Primary Care Innovation at London Healthcare Conferences
4. CVS Caremark Emphasizes Commitment to Older Americans at Annual American Society on Aging Conference
5. Accordant Health Services, a CVS Caremark Company, Receives URAC Case Management Accreditation
6. CVS Caremark CEO Addresses Economic Club of Pittsburgh on Reinventing Pharmacy for Better Health
7. CVS Caremark Appoints New Chief Digital Officer to Lead Digital Innovation Team
8. CVS Caremark Encourages Heart Healthy Behavior During American Heart Month
9. CVS Caremark Corporation To Hold Fourth Quarter 2012 Conference Call
10. CVS Caremark Statement and Response to CMS Action
11. CVS Caremark Provides Strong Growth Outlook for 2013 and Beyond, Announces 38%Dividend Increase and Outlines Strategic Growth Framework
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 2015  EP Global Communications, Inc. (Public OTC: EPGL) announced ... the Company about discussing EPGL,s electronic contact lens ... August 3, 2015.  Novartis CEO Joe Jimenez ... coming electronic contact lens market could be worth ... several years.  Novartis partnered with Google in 2014 ...
(Date:7/30/2015)... SOUTH PLAINFIELD, N.J., July 30, 2015 PTC ... corporate update and reported financial results for the second ... is progressing on many fronts across the organization.  We ... largest Duchenne muscular dystrophy clinical trial ever conducted with ... W. Peltz, Ph.D., Chief Executive Officer, PTC Therapeutics, Inc. ...
(Date:7/30/2015)...  Growth of the U.S. nonprescription market is primarily ... users to the OTC market. Due to an increasingly ... switch activity over the next five years with several ... brands entering the market into existing categories. ... (even those with low to moderate likelihood), the market ...
Breaking Medicine Technology:PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
... , ENGLEWOOD, Colo., Dec. 7 ... DoseEdge(TM), during this week,s ASHP Midyear Clinical Meeting (MCM). ... safety and pharmacy efficiency through the management of IV ... into current pharmacy practice and techniques, while providing a ...
... , CARLSBAD, Calif., Dec. 7 Genoptix, Inc. (Nasdaq: ... the Company,s participation at the Deutsche Bank 2009 MedTools Investor ... Mass. on December 9-10, 2009. , Genoptix,s EVP ... the Company on Wednesday, December 9, 2009. He will ...
Cached Medicine Technology:Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2
(Date:8/1/2015)... ... August 01, 2015 , ... Lume Wellness creators Alex, Robert, and Sam have ... the Apple AppStore. , The app is designed to track various metrics of ... tool to view personal health and use this information for positive behavior modification. Lume ...
(Date:7/31/2015)... ... 2015 , ... Ticket Down is a reputable source of authentic tickets for the 2015 ... Fans of every genre of music will have an act they are excited to see ... festival, the following artists will perform: Sam Smith, Coldplay, Kenny Chesney, The Who, Jason ...
(Date:7/31/2015)... ... , ... Precision Aesthetics is New York’s only Thermage skin tightening pinnacle and ... of Exilis non-surgical fat reduction in New York. Due to its unparalleled level ... clientele. Many patients travel to New York to get their non-surgical skin tightening ...
(Date:7/31/2015)... NY (PRWEB) , ... July 31, 2015 , ... There’s ... as possible, even when it comes time to cook the next meal, making July ... of July by practicing best grilling tips and recipes. , Make the next cookout ...
(Date:7/31/2015)... NY (PRWEB) , ... July 31, 2015 , ... Ticket ... Theatre . Those looking to catch a new and refreshing show on Broadway, ... numerous awards and achievements including an Obie Award, Outer Critics Circle Award, Drama Desk ...
Breaking Medicine News(10 mins):Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 3Health News:King Kullen Honors National Hot Dog and Blueberry Month 2Health News:King Kullen Honors National Hot Dog and Blueberry Month 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 4Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 5Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 6Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 7
... 28 Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT ... and commercialization of proprietary products that address important therapeutic ... Glenn A. Oclassen, President & Chief Executive Officer, is ... Science Conference in New York City on Wednesday, June ...
... LaboratoryALBUQUERQUE, N.M., May 28 Exagen Diagnostics, Inc. today ... to assist physicians with diagnosing Irritable Bowel Syndrome (IBS) ... tests at Digestive Disease Week 2009 in Chicago, May ... identifies patients with IBS, while the eXaIBD ...
... to Vote WHITE Proxy Card to Re-Elect Highly-Qualified ... Opposition SlateTUCSON, Ariz., May 28 The Providence ... announced that it has issued the following letter ... to vote at the upcoming 2009 Annual Meeting ...
... Quality, Cutting CostsSILVER SPRING, Md., May 28 ... outcomes management systems, today issued a white paper ... Congress to require consumer-driven outcomes management as a ... industry. "Consumer-Driven Outcomes Management: A New Paradigm for ...
... May 28 NXGen Holdings, Inc. (Pink Sheets: ... is entering the $17.5 Billion Household and Industrial ... Green Bridge Industries, Inc., a company which manufactures ... NXGen Holdings, Inc. acquired Green Bridge Industries in ...
... Data To Be Presented at 2009 ASCO Annual ... Combination with Docetaxel/Prednisone as First-Line Therapy for Metastatic ... Host Analyst and Investor Briefing to Discuss Data ... Calif., May 28 Poniard Pharmaceuticals, Inc. (Nasdaq: ...
Cached Medicine News:Health News:Transcept Pharmaceuticals to Present at Needham Life Sciences Conference on June 10, 2009 2Health News:Transcept Pharmaceuticals to Present at Needham Life Sciences Conference on June 10, 2009 3Health News:Exagen Launches New Diagnostic Assays for Bowel Disease at Digestive Disease Week Conference 2Health News:Providence Service Corporation Issues Letter to Stockholders 2Health News:Providence Service Corporation Issues Letter to Stockholders 3Health News:Providence Service Corporation Issues Letter to Stockholders 4Health News:Providence Service Corporation Issues Letter to Stockholders 5Health News:Providence Service Corporation Issues Letter to Stockholders 6Health News:Providence Service Corporation Issues Letter to Stockholders 7Health News:Providence Service Corporation Issues Letter to Stockholders 8Health News:Providence Service Corporation Issues Letter to Stockholders 9Health News:MyOutcomes Urges Government Leaders to Employ Consumer-Driven Outcomes Management in Reforming Behavioral Health System 2Health News:MyOutcomes Urges Government Leaders to Employ Consumer-Driven Outcomes Management in Reforming Behavioral Health System 3Health News:NXGen Holdings, Inc. Enters the $17.5 Billion Household and Industrial Cleaning Products Industry through the Acquisition of Green Bridge Industries, Inc. 2Health News:Poniard Pharmaceuticals Announces Positive Efficacy and Safety Data From Phase 2 Clinical Trial of Picoplatin in Men With Metastatic Prostate Cancer 2Health News:Poniard Pharmaceuticals Announces Positive Efficacy and Safety Data From Phase 2 Clinical Trial of Picoplatin in Men With Metastatic Prostate Cancer 3Health News:Poniard Pharmaceuticals Announces Positive Efficacy and Safety Data From Phase 2 Clinical Trial of Picoplatin in Men With Metastatic Prostate Cancer 4Health News:Poniard Pharmaceuticals Announces Positive Efficacy and Safety Data From Phase 2 Clinical Trial of Picoplatin in Men With Metastatic Prostate Cancer 5Health News:Poniard Pharmaceuticals Announces Positive Efficacy and Safety Data From Phase 2 Clinical Trial of Picoplatin in Men With Metastatic Prostate Cancer 6
... Advanced Magnetics' contrast agent for use with MRI ... the first organ-specific MRI contrast agent to be ... agent is taken up by macrophages found only ... tumors. The liver is a principal site for ...
... new Contrast Agent for Ultrasonography ... stabilized SF6 microbubbles. The size ... 1 and 10 m, and ... and 5 x 108 per ...
... VISIPAQUE is the only isosmolar contrast medium (IOCM) ... to that of blood, VISIPAQUE was designed for ... only contrast medium formulated with sodium and calcium ... VISIPAQUE received FDA approval for use in children ...
... (iopromide) injection is a nonionic, iodinated, ... administration. Introduced in the U.S. in ... in Europe, ULTRAVIST today is ... has established a positive clinical experience ...
Medicine Products: